Evidence map›Paper›PMID 22515733›Full record

ArticleBiochemistry2012

Conformational change in rhomboid protease GlpG induced by inhibitor binding to its S' subsites.

Yi Xue, Somenath Chowdhury, Xuying Liu, Yoshinori Akiyama, Jonathan Ellman, Ya Ha

Abstract read
In one paragraph

Article in Biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yi XueDepartment of Pharmacology, Yale School of Medicine, New Haven, Connecticut 06520, USA.
Somenath Chowdhury
Xuying Liu
Yoshinori Akiyama
Jonathan Ellman
Ya Ha
Yale University · USKyoto University · JP

Funding

Structural studies of intramembrane protease GlpGR01GM082839 · NIGMS · YALE UNIVERSITY · PI HA, YA · 2008 to 2011
$1.3M
NIGMS NIH HHS GM082839NIGMS NIH HHS R01 GM082839
6 · The paper itself

Abstract

Rhomboid protease conducts proteolysis inside the hydrophobic environment of the membrane. The conformational flexibility of the protease is essential for the enzyme mechanism, but the nature of this flexibility is not completely understood. Here we describe the crystal structure of rhomboid protease GlpG in complex with a phosphonofluoridate inhibitor, which is covalently bonded to the catalytic serine and extends into the S' side of the substrate binding cleft. Inhibitor binding causes subtle but extensive changes in the membrane protease. Many transmembrane helices tilt and shift positions, and the gap between S2 and S5 is slightly widened so that the inhibitor can bind between them. The side chain of Phe-245 from a loop (L5) that acts as a cap rotates and uncovers the opening of the substrate binding cleft to the lipid bilayer. A concurrent turn of the polypeptide backbone at Phe-245 moves the rest of the cap and exposes the catalytic serine to the aqueous solution. This study, together with earlier crystallographic investigation of smaller inhibitors, suggests a simple model for explaining substrate binding to rhomboid protease.

Indexed as

AlanineBinding SitesCatalysisCrystallizationCrystallography, X-RayDNA-Binding ProteinsEndopeptidasesEscherichia coli ProteinsMembrane ProteinsModels, MolecularOrganophosphorus CompoundsProtease InhibitorsProtein ConformationProtein Structure, TertiarySerineAlanineDNA-Binding ProteinsEndopeptidasesEscherichia coli ProteinsGlpG protein, E coliMembrane ProteinsOrganophosphorus CompoundsProtease InhibitorsSerine

Identifiers

PMID22515733
PMCPMC3351039
OpenAlexW1990205832

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.